Literature DB >> 35546982

Role of Toll-Like Receptor 5 in the Development of Ulcerative Colitis.

A Falah Alshimerry1, R Ghalib Farhood1, H Hasan Shakir2.   

Abstract

Inflammatory bowel disease (ulcerative colitis and Crohn's disease) is a remitting and relapsing disease that affects millions of people worldwide. In the intestine, homeostasis between repair and signaling of the proinflammatory of the immune system is needful for the upkeep of intestinal balance. The recent evidence has highlighted the dysfunction of the immune system, particularly toll-like receptors (TLRs)-mediated immune system dysfunction, in the ulcerative colitis pathogenesis. The main objective of the current study was to analyze the expression level of TLR5 at the mRNA in ulcerative colitis patients and investigate the impacts of the TLR5 gene as genetic factors that contribute to the development of ulcerative colitis. The paraffin-embedded blocks were retrospectively collected from 25 patients diagnosed with ulcerative colitis and 25 cases with normal colonic tissue. The quantitative real-time polymerase chain reaction method was employed for the estimation of TLR5at the mRNA level. The analysis of the data of TLR5 gene expression revealed that the expression of this gene is downregulated in ulcerative colitis cases, as compared to that in normal colonic tissue. As evidenced by the results of this study, TLR5 may play a role in the development of ulcerative colitis; therefore, it should be introduced in the management of ulcerative colitis.

Entities:  

Keywords:  Bowel disease; TLR5; Ulcerative Colitis

Mesh:

Substances:

Year:  2021        PMID: 35546982      PMCID: PMC9083863          DOI: 10.22092/ari.2021.356358.1825

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  20 in total

1.  A toll-like receptor that prevents infection by uropathogenic bacteria.

Authors:  Dekai Zhang; Guolong Zhang; Matthew S Hayden; Matthew B Greenblatt; Crystal Bussey; Richard A Flavell; Sankar Ghosh
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 2.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

Review 3.  Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.

Authors:  D Roggenbuck; D Reinhold; D C Baumgart; P Schierack; K Conrad; M W Laass
Journal:  Adv Clin Chem       Date:  2016-06-30       Impact factor: 5.394

4.  Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages.

Authors:  Sang Hoon Rhee; Bryan W Jones; Vladimir Toshchakov; Stefanie N Vogel; Matthew J Fenton
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 5.  Inflammatory bowel disease: pathogenesis.

Authors:  Yi-Zhen Zhang; Yong-Yu Li
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Can bacterial interference prevent infection?

Authors:  G Reid; J Howard; B S Gan
Journal:  Trends Microbiol       Date:  2001-09       Impact factor: 17.079

7.  Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase.

Authors:  S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

8.  Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.

Authors:  E Cario; D K Podolsky
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Bacterial flagellin is a dominant antigen in Crohn disease.

Authors:  Michael J Lodes; Yingzi Cong; Charles O Elson; Raodoh Mohamath; Carol J Landers; Stephan R Targan; Madeline Fort; Robert M Hershberg
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.